The INTEGRATION consortium held its annual meeting of the third year of the project on 21st and 22nd March 2024 in Paris. The INTEGRATION project involves the University of Sciences, Techniques and Technologies of Bamako, USTTB (Mali), CNRST-Centre National De La Recherche Scientifique et Technologique/IRSS-Institut de Recherche en Sciences de la Santé (Burkina Faso), Institut de Recherche pour le Développement, IRD (France), Liverpool School of Tropical Medicine, LSTM (United Kindom) and R-Evolution Worldwide Srl – Impresa Sociale, R-evoWW (Italy).

Click here for more information:  Annual Project Meeting Y3 – INTEGRATION (integration-iptp-smc.org)

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

OPTIMAL-RSV AFRICA PROPOSAL SUBMITTED TO EDCTP3 TO IMPROVING NEWBORN PROTECTION AGAINTS RESPIRATORY INFECTION IN AFRICA

Respiratory infections remain one of the main causes of illness and death among newborns in sub-Saharan Africa. Respiratory Syncytial Virus (RSV) is a major contributor to severe disease in the

NeuroSolve project obtained the Clinical Trial Ethical Approval in Zambia too!

After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

HANTAAN-VAX-EU-Proposal submitted under the Horizon Europe call for a multiplatform vaccine against Hantaan virus

Hantaan virus (HTNV) is one of the main causes of haemorrhagic fever with renal syndrome (HFRS), a severe disease affecting endemic regions across Asia, with growing concern over its geographical